OSL Half Yearly Report and Accounts 23/02/21 PRICE SENSITIVE download Created with Sketch. 415.31KB Share OSL Half-Yearly Report Results 23/02/21 PRICE SENSITIVE download Created with Sketch. 290.47KB Share OSL OncoSil Investor Update 18/02/21 PRICE SENSITIVE download Created with Sketch. 1.15MB Share OSL Appendix 4C - quarterly 28/01/21 PRICE SENSITIVE download Created with Sketch. 491.37KB Share OSL Appointment of Chief Executive Officer 21/01/21 PRICE SENSITIVE download Created with Sketch. 273.13KB Share OSL OncoSil FY21 half yearly review 18/01/21 PRICE SENSITIVE download Created with Sketch. 245.86KB Share OSL Termination of Mr Daniel Kenny as Chief Executive Officer 02/12/20 PRICE SENSITIVE download Created with Sketch. 210.14KB Share OSL OncoSil receives Swiss regulatory approval 05/11/20 PRICE SENSITIVE download Created with Sketch. 220.13KB Share OSL OncoSil achieves first commercial sale 22/10/20 PRICE SENSITIVE download Created with Sketch. 302.82KB Share OSL Appendix 4C - quarterly 21/10/20 PRICE SENSITIVE download Created with Sketch. 506.86KB Share OSL Positive PanCO trial update on resected cohort 20/10/20 PRICE SENSITIVE download Created with Sketch. 319.8KB Share OSL 2020 AGM CEO Presentation 20/10/20 PRICE SENSITIVE download Created with Sketch. 984.59KB Share OSL Receipt of $2.8m R&D Tax Incentive Refund 23/09/20 PRICE SENSITIVE download Created with Sketch. 208.4KB Share OSL Investor Update 28/08/20 PRICE SENSITIVE download Created with Sketch. 1.34MB Share OSL OncoSil receives Malaysian regulatory approval 28/08/20 PRICE SENSITIVE download Created with Sketch. 264.36KB Share OSL Preliminary Final Report - Appendix 4E Announcement 19/08/20 PRICE SENSITIVE download Created with Sketch. 286.58KB Share OSL Appendix 4E and Annual Report 19/08/20 PRICE SENSITIVE download Created with Sketch. 3.13MB Share OSL Appendix 4C - quarterly 30/07/20 PRICE SENSITIVE download Created with Sketch. 507.9KB Share OSL HDE filing submitted in US for Bile Duct Cancer treatment 28/07/20 PRICE SENSITIVE download Created with Sketch. 215.69KB Share OSL OncoSil presents clinical data at ESMO World Congress 03/07/20 PRICE SENSITIVE download Created with Sketch. 538.69KB Share OSL OncoSil files for TGA registration 02/07/20 PRICE SENSITIVE download Created with Sketch. 221.05KB Share OSL OncoSil receives Singapore regulatory approval 01/06/20 PRICE SENSITIVE download Created with Sketch. 258.23KB Share OSL Entitlement Offer Results and Shortfall Notification 26/05/20 PRICE SENSITIVE download Created with Sketch. 216.89KB Share OSL OncoSil Entitlement Offer Booklet 12/05/20 PRICE SENSITIVE download Created with Sketch. 503.35KB Share OSL Allotment of Securities under Institutional Placement 08/05/20 PRICE SENSITIVE download Created with Sketch. 95.15KB Share OSL Proposed issue of Securities - OSL 04/05/20 PRICE SENSITIVE download Created with Sketch. 36.7KB Share OSL Investor Presentation 04/05/20 PRICE SENSITIVE download Created with Sketch. 2.82MB Share OSL OncoSil launches Capital Raising 04/05/20 PRICE SENSITIVE download Created with Sketch. 472.3KB Share OSL OncoSil submits for ASEAN and APAC approvals 04/05/20 PRICE SENSITIVE download Created with Sketch. 218.35KB Share OSL Appendix 4C - quarterly 30/04/20 PRICE SENSITIVE download Created with Sketch. 508.53KB Share OSL Trading Halt 29/04/20 PRICE SENSITIVE download Created with Sketch. 205.63KB Share OSL Oncosil breakthrough device receives CE Marking approval 01/04/20 PRICE SENSITIVE download Created with Sketch. 231.96KB Share OSL Clarification Statement 27/03/20 PRICE SENSITIVE download Created with Sketch. 140.73KB Share OSL Pause in Trading 27/03/20 PRICE SENSITIVE download Created with Sketch. 115.1KB Share OSL FDA Grants Breakthrough Device Designation 18/03/20 PRICE SENSITIVE download Created with Sketch. 192.2KB Share OSL Half Yearly Report and Accounts 27/02/20 PRICE SENSITIVE download Created with Sketch. 459.19KB Share OSL Appendix 4C - quarterly 30/01/20 PRICE SENSITIVE download Created with Sketch. 337.4KB Share OSL CE Mark Update 19/11/19 PRICE SENSITIVE download Created with Sketch. 251.89KB Share OSL Positive CE Mark Status Report 01/11/19 PRICE SENSITIVE download Created with Sketch. 139.51KB Share OSL Appendix 4C - quarterly 31/10/19 PRICE SENSITIVE download Created with Sketch. 560.34KB Share OSL OncoSil AGM CEO Presentation 29/10/19 PRICE SENSITIVE download Created with Sketch. 2.85MB Share OSL Updated Clinical Evaluation Report to BSI 28/10/19 PRICE SENSITIVE download Created with Sketch. 445.65KB Share OSL Receipt of $3.8M R&D Tax Incentive 18/10/19 PRICE SENSITIVE download Created with Sketch. 140.03KB Share OSL Appendix 4E and Full Year Statutory Accounts 23/08/19 PRICE SENSITIVE download Created with Sketch. 1.16MB Share OSL Appendix 4C - quarterly 31/07/19 PRICE SENSITIVE download Created with Sketch. 909.43KB Share OSL Response to ASX Price Query 26/07/19 PRICE SENSITIVE download Created with Sketch. 697.9KB Share OSL Appendix 4C - quarterly 30/04/19 PRICE SENSITIVE download Created with Sketch. 904.58KB Share OSL Update - CE Marking Application 29/03/19 PRICE SENSITIVE download Created with Sketch. 543.45KB Share OSL CE Marking Update 25/03/19 PRICE SENSITIVE download Created with Sketch. 545.61KB Share OSL Half Yearly Report and Accounts 20/02/19 PRICE SENSITIVE download Created with Sketch. 981.79KB Share OSL Appendix 4C - quarterly 31/01/19 PRICE SENSITIVE download Created with Sketch. 1.06MB Share OSL Appendix 4C - quarterly 29/10/18 PRICE SENSITIVE download Created with Sketch. 1.12MB Share OSL PanCo Study Interim Analysis 25/10/18 PRICE SENSITIVE download Created with Sketch. 834.73KB Share OSL R&D Refund - 2018 Financial Year 24/09/18 PRICE SENSITIVE download Created with Sketch. 638.37KB Share OSL IQVIA appointed EU Market Access and Reimbursement Advisor 30/08/18 PRICE SENSITIVE download Created with Sketch. 728.53KB Share OSL Preliminary Final Report 22/08/18 PRICE SENSITIVE download Created with Sketch. 1.89MB Share OSL Appendix 4C & Quarterly Update 25/07/18 PRICE SENSITIVE download Created with Sketch. 1.07MB Share OSL Response to Price Query 31/05/18 PRICE SENSITIVE download Created with Sketch. 1002.99KB Share OSL Oncosil submits Clinical Study Report to Notified Body 14/05/18 PRICE SENSITIVE download Created with Sketch. 660.34KB Share OSL Appendix 4C & Quarterly Update 26/04/18 PRICE SENSITIVE download Created with Sketch. 1007.79KB Share OSL Clinical Programme Update 04/04/18 PRICE SENSITIVE download Created with Sketch. 737.83KB Share OSL Oncosil Medical Share Purchase Plan 28/03/18 PRICE SENSITIVE download Created with Sketch. 1.27MB Share OSL Successful Completion of Capital Raising 22/03/18 PRICE SENSITIVE download Created with Sketch. 529.32KB Share OSL Presentation-Surgical Resection Outcomes and Capital Raising 21/03/18 PRICE SENSITIVE download Created with Sketch. 3.25MB Share OSL Surgical Resection Outcomes and Capital Raising 21/03/18 PRICE SENSITIVE download Created with Sketch. 539.5KB Share OSL Trading Halt 21/03/18 PRICE SENSITIVE download Created with Sketch. 658.38KB Share OSL Positive Early Study Results Continue 28/02/18 PRICE SENSITIVE download Created with Sketch. 844.65KB Share OSL Appendix 4D & Half Yearly Report and Accounts 21/02/18 PRICE SENSITIVE download Created with Sketch. 1.03MB Share OSL First Subject Recruited in the United States 08/02/18 PRICE SENSITIVE download Created with Sketch. 650.6KB Share OSL Response to ASX Appendix 4C Query 08/02/18 PRICE SENSITIVE download Created with Sketch. 895.01KB Share OSL Appendix 4C & Quarterly Update 29/01/18 PRICE SENSITIVE download Created with Sketch. 1.01MB Share OSL Additional Receipt of $0.6m R&D Tax Incentive Refund 16/01/18 PRICE SENSITIVE download Created with Sketch. 524.73KB Share OSL Appendix 3C - Employee Loan Share Buy Back 11/01/18 PRICE SENSITIVE download Created with Sketch. 188.19KB Share OSL Progress Update on Global Pancreatic Cancer Clinical Study 21/12/17 PRICE SENSITIVE download Created with Sketch. 675.07KB Share OSL Appendix 4C & Quarterly Update 31/10/17 PRICE SENSITIVE download Created with Sketch. 341.8KB Share OSL Positive Early Study Results Presented at EANM Congress 23/10/17 PRICE SENSITIVE download Created with Sketch. 754.74KB Share OSL Progress Update on Global Pancreatic Cancer Clinical Study 16/10/17 PRICE SENSITIVE download Created with Sketch. 134.68KB Share OSL R&D Refund 25/09/17 PRICE SENSITIVE download Created with Sketch. 136.51KB Share OSL Progress update on Global Pancreatic Cancer Clinical Study 22/09/17 PRICE SENSITIVE download Created with Sketch. 149.74KB Share OSL Appendix 4E - Preliminary Final Report 30 June 2017 24/08/17 PRICE SENSITIVE download Created with Sketch. 947.07KB Share OSL First UK subject recruited 22/08/17 PRICE SENSITIVE download Created with Sketch. 142.56KB Share OSL CE Mark & Quarterly Activity Update 31/07/17 PRICE SENSITIVE download Created with Sketch. 426.3KB Share OSL Second subject recruited at Monash Health Melbourne 11/05/17 PRICE SENSITIVE download Created with Sketch. 114.65KB Share OSL Appendix 4C and Quarterly update 27/04/17 PRICE SENSITIVE download Created with Sketch. 270.86KB Share OSL First OncoSil Device Implantation procedure completed 26/04/17 PRICE SENSITIVE download Created with Sketch. 107.68KB Share OSL Specialised Therapeutics Australia supporting OncoSil study 20/04/17 PRICE SENSITIVE download Created with Sketch. 147.08KB Share OSL US IRB Approval, MD Anderson Cancer Centre 19/04/17 PRICE SENSITIVE download Created with Sketch. 130.17KB Share OSL UK Central Ethics Approval 04/04/17 PRICE SENSITIVE download Created with Sketch. 148.87KB Share OSL First subject recruited 28/03/17 PRICE SENSITIVE download Created with Sketch. 148.1KB Share OSL Appendix 4D & Half Year Accounts 23/02/17 PRICE SENSITIVE download Created with Sketch. 1.38MB Share OSL MHRA Approval to commence study in UK 13/02/17 PRICE SENSITIVE download Created with Sketch. 134.81KB Share OSL CE Mark Update 08/02/17 PRICE SENSITIVE download Created with Sketch. 148.59KB Share OSL Ethics Approval for OncoPac Clinical Study 02/02/17 PRICE SENSITIVE download Created with Sketch. 141.38KB Share OSL Appendix 4C - Quarterly Cash Flow 27/01/17 PRICE SENSITIVE download Created with Sketch. 237.57KB Share OSL Pancreatic cancer clinical study update 28/11/16 PRICE SENSITIVE download Created with Sketch. 150.88KB Share OSL Appendix 4C - Quarterly Cash Flow-OSL.AX 27/10/16 PRICE SENSITIVE download Created with Sketch. 236.8KB Share OSL Receipt of $2.3m R & D Tax Incentive Refund-OSL.AX 26/09/16 PRICE SENSITIVE download Created with Sketch. 130.38KB Share OSL Appendix 4E - Preliminary final report 30 June 2016-OSL.AX 30/08/16 PRICE SENSITIVE download Created with Sketch. 666.71KB Share OSL Hot Calibration Run of the OncoSil Device-OSL.AX 18/08/16 PRICE SENSITIVE download Created with Sketch. 128.24KB Share OSL FDA IDE Approval-OSL.AX 02/08/16 PRICE SENSITIVE download Created with Sketch. 642.21KB Share
